MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...

The US Food and Drug Administration (FDA) recently approved a first of its kind use-at-home cervical cancer screening tool. Known as “Teal Wand,” it allows women to collect their vaginal sample at ...

Patients had a higher risk of recurrence if they had grade 3 tumors or tumors measuring at least 2 cm. New research suggests that patients with early-stage cervical cancer and no high-risk factors ...

Another story making headlines recently was an announcement from the FDA that could have a big impact on cervical cancer screenings. Andrea, tell us more about that. Garcia: Well, last Friday, the FDA ...